Chronimed Initiates Preemptive Defense, Bayer Infringement Suit Follows
This article was originally published in The Gray Sheet
Executive Summary
Chronimed's DiaScreen urinalysis test strips for leukocytes do not incorporate analytical processes or agents claimed in Bayer's U.S. patent covering glucose test strip technology, Chronimed maintains in a declaratory judgment action filed against Bayer in Minneapolis federal court.
You may also be interested in...
Bayer v. Chronimed
Firms announce Dec. 7 settlement of patent litigation under which both parties will continue to market their products,and Chronimed's test strips will include a redesign of the DiaScreen leukocyte test. Bayer Diagnostics had filed suit in March 1999, alleging that the DiaScreen leukocyte test infringed its Multistix line of urine test strips (1"The Gray Sheet" March 15, 1999, p. 29)
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.